In summary, the studies described here show that CXCR7 is a hypoxia-responsive mediator of SDF-1α-induced glioma cell migration and support the development of therapeutic agents for the pharmacological inhibition of CXCR4 and CXCR7 to control glioma cell migration. Here, ACKR3 is linked to glioma.